Laura Ciaffi - Concepedia

Author

Laura Ciaffi

Institut de Recherche pour le Développement ORCID

Also Known As

A Bissek, A. Calmy, Ciaffi, Laura, L Ciaffi, L. Ciaffi, LAURA CIAFFI, Laura Ciaffi, Sabrina Eymard-Duvernay

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Institut de Recherche pour le Développement Université de Montpellier Médecins Sans Frontières Central Hospital of Yaoundé Centre Hospitalier Universitaire de Montpellier

About

Laura Ciaffi is an author at Institut de Recherche pour le Développement specializing in medicine, pharmacotherapy, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	8	549
2	Public Health	3	3	131
3	Epidemiology	3	3	131
4	Global Health	2	4	368
5	Gastroenterology	1	1	87

Laura Ciaffi

Publications

926

Citations

H-Index

Page 1

	Year	Citations
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack, The Lancet HIV Open LabelWeek 96Treatment And PreventionGlobal HealthAntiviral Drug Development	2020	155
BURULI ULCER DISEASE IN CAMEROON REDISCOVERED J Noeske, Christopher Kuaban, Simona Rondini, American Journal of Tropical Medicine and Hygiene Active BuBuruli UlcerKlebsiella PneumoniaeClinical EpidemiologyGastroenterology	2004	87
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, The Lancet HIV Lamivudine Dual TherapySuperiority TrialProtease InhibitorTreatment And PreventionGlobal Health	2017	71
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, Nature Communications	2021	61
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial Maryline Bonnet, Nilesh Bhatt, Elisabeth Baudin, The Lancet Infectious Diseases Treatment And PreventionAntiviral TherapyTuberculosisPharmacotherapyChronic Viral Infection	2013	50
Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon Anke Bourgeois, Christian Laurent, Rose Mougnutou, Antiviral Therapy	2005	46
Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting Nongodo Firmin Kaboré, Armel Poda, Jacques Zoungrana, BMC Nephrology	2019	45
Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon Vanessa Christinet, Éric Comte, Laura Ciaffi, Open Forum Infectious Diseases	2014	42
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, AIDS	2015	41
Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon Christian Laurent, Anke Bourgeois, Eitel Mpoudi‐Ngolé, AIDS Research and Human Retroviruses	2008	40

Page 1